FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/01/011439 [Registered on: 19/01/2018] Trial Registered Retrospectively
Last Modified On:
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Single Arm Study 
Public Title of Study   A trial to test the safety of a herbal formulation 
Scientific Title of Study   Phase 1 clinical trial for assessment of safety of a multi component botanical formulation SKBSHYAM 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road Aligarh

Aligarh
UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road Aligarh


UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Ashok Kumar 
Designation  Chairman 
Affiliation  SK Biotherapeutics Pvt. Ltd. (Previously SK Biolabs) 
Address  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road Aligarh


UTTAR PRADESH
202001
India 
Phone  8126688922  
Fax    
Email  ashok846@gmail.com  
 
Source of Monetary or Material Support  
SK Biolabs 15, Prayag Sarover Ramghat Road Aligarh-202001 (U.P.) India 
 
Primary Sponsor  
Name  SK Biolabs 
Address  15, Prayag Sarover Ramghat Road Aligarh-202001 (U.P.) India 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Ashok Kumar  SK Biolabs  Drug Discovery Division, 15, Prayag Sarover, Ramghat Road, Aligarh-202001
Aligarh
UTTAR PRADESH 
8126688922

ashok846@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SK Biolabs Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  Healthy Human Volunteers 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  No comparator agent  Not applicable 
Intervention  SKBSHYAM  Apply formulation on skin for 15 minutes daily for 30 days. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  81.00 Year(s)
Gender  Both 
Details  Healthy human volunteers 
 
ExclusionCriteria 
Details  Patients suffering from any disease. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Any toxic side effects after application of SKBSHYAM on skin such as irritation, redness, inflammation, edema, urticaria, fever, vomiting, nausea, faintness, cough, rashes etc.  30 minutes 
 
Secondary Outcome  
Outcome  TimePoints 
Any toxic side effects after application of SKBSHYAM on skin such as irritation, redness, inflammation, edema, urticaria, fever, vomiting, nausea, faintness, cough, rashes etc.  1 month 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   Phase 1 
Date of First Enrollment (India)   01/04/2002 
Date of Study Completion (India) 01/08/2002 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="4"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Multi component botanical formulation SKBSHYAM causes no toxicity in healthy human volunteers. 
Close